Hanover, NH, United States of America

George A O'Toole

This inventor holds 4 USPTO granted patents and 1 published patent application. Top assignees: Dartmouth College, Dartmouth-Hitchcock Clinic, California Institute of Technology. Active years: 2006-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: George A O'Toole. Retrieved from https://idiyas.com/inventor/george-a-o-toole

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 4 

% Patents Active = 100.0

Average Co-Inventor Count = 2.2

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 2006-2025

Loading Chart...
4 patents (USPTO):Explore Patents

Title: Innovations of George A O'Toole

Introduction

George A O'Toole is a notable inventor based in Hanover, NH (US). He has made significant contributions to the field of microbiome research, particularly in relation to cystic fibrosis. With a total of 4 patents, O'Toole's work has the potential to impact the treatment and management of this challenging condition.

Latest Patents

O'Toole's latest patents focus on methods for altering the intestinal microbiome in patients with cystic fibrosis. The present disclosure relates to a method of altering the intestinal microbiome in a patient having cystic fibrosis, comprising administering at least one agent to a patient and allowing the agent to alter the intestinal microbiome. This innovative approach aims to improve the health outcomes for individuals suffering from this genetic disorder.

Career Highlights

Throughout his career, George A O'Toole has worked with prestigious institutions such as Dartmouth College and the California Institute of Technology. His research has garnered attention for its potential to revolutionize the understanding and treatment of cystic fibrosis.

Collaborations

O'Toole has collaborated with esteemed colleagues, including Juliette C Madan and Dianne K Newman. Their combined expertise has contributed to advancements in microbiome research and its applications in medicine.

Conclusion

George A O'Toole's innovative work in altering the intestinal microbiome represents a significant advancement in the treatment of cystic fibrosis. His contributions to the field highlight the importance of research in improving patient care and outcomes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…